1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Cancer Biological Therapy Market, by Product
6.1. Introduction
6.2. Cancer Growth Blockers
6.3. Monoclonal Antibodies
6.4. Vaccines

7. Cancer Biological Therapy Market, by Distribution Channel
7.1. Introduction
7.2. Hospital
7.3. Retail & Mail Order Pharmacies

8. California Cancer Biological Therapy Market

9. Florida Cancer Biological Therapy Market

10. Illinois Cancer Biological Therapy Market

11. New York Cancer Biological Therapy Market

12. Ohio Cancer Biological Therapy Market

13. Pennsylvania Cancer Biological Therapy Market

14. Texas Cancer Biological Therapy Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. AbbVie, Inc
16.2. Amgen Inc.
16.3. Astellas Pharma Inc.
16.4. AstraZeneca PLC
16.5. Bausch Health Companies Inc.
16.6. Bayer AG
16.7. Bristol-Myers Squibb
16.8. Celgene Corporation
16.9. Eisai Co., Ltd.
16.10. Eli Lilly and Company
16.11. EnGeneIC Ltd
16.12. F. Hoffmann-La Roche AG
16.13. GlaxoSmithKline PLC
16.14. Hikma Pharmaceuticals PLC
16.15. Incyte Corp
16.16. Johnson & Johnson Services, Inc,
16.17. Merck & Co., Inc.
16.18. Novartis International AG
16.19. Otsuka Pharmaceutical Co., Ltd
16.20. Pfizer, Inc
16.21. Sanofi SA
16.22. Spectrum Pharmaceuticals, Inc.
16.23. Takeda Pharmaceutical Company Limited
16.24. Teva Pharmaceutical Industries Ltd

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 16. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 21. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 22. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CANCER BIOLOGICAL THERAPY MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: SCORES
TABLE 12. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: BUSINESS STRATEGY
TABLE 13. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: PRODUCT SATISFACTION
TABLE 14. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: RANKING
TABLE 15. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 16. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: MERGER & ACQUISITION
TABLE 17. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 18. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 19. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: INVESTMENT & FUNDING
TABLE 20. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 21. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

AbbVie, Inc
Amgen Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bausch Health Companies Inc.
Bayer AG
Bristol-Myers Squibb
Celgene Corporation
Eisai Co., Ltd.
Eli Lilly and Company
EnGeneIC Ltd
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Incyte Corp
Johnson & Johnson Services, Inc,
Merck & Co., Inc.
Novartis International AG
Otsuka Pharmaceutical Co., Ltd
Pfizer, Inc
Sanofi SA
Spectrum Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd